What an incredible experience at the Pulmonary Fibrosis Foundation Education Summit the last two days! It was an inspiring event filled with insightful presentations, engaging discussions, and a strong sense of community. Our CEO, Lyn Baranowski, gave an overview of our lead program AP01, an optimized inhaled formulation of pirfenidone, being developed for the treatment of #PulmonaryFibrosis. Thank you to the Pulmonary Fibrosis Foundation team and everyone who joined us.
Avalyn Pharma的动态
最相关的动态
-
Quick mini CME activities. Explore the new nAMD Courses: New Durable Anti-VEGF Therapies collection. Learn How Patients Can Benefit from the New Durable Anti-VEGF Therapies, Faricimab and Aflibercept 8 mg. https://ow.ly/Kb0Q50UfoUR
-
-
An International Self-Employed Medical Device & Healthcare Business Developer, Sales and Marketing Specialist.
Why to choose Nephrospec?? Because it is non-invasive and painless, no radiation is needed, and it is an outpatient therapy using a low-intensity Acoustic Therapy (eHAT) device for the treatment of CKD and hypertension.? Our patented technology promotes new blood vessel formation, and restores damaged tissue function. It also offers significant cost savings, up to 80% compared to dialysis! The Nephrospec? is a complementary solution to optimise medical care for CKD and?hypertension. Improvement of kidney function within a few weeks ONLY!?and delays the start of outpatient treatment for dialysis. To learn more, please drop me a line; thank you!.. #kidneyhealth #chronickidneydisease #nephrology #nephrologists #curespec #nephrospec #delaydialysis #bloodpressure #hypertension #medicalinnovation #medicaldevice #medtech?
Mark your calendars! Join us for Prof. Wolak's exclusive oral session at Convention Hall I C on Saturday, June 6, at 17:55. ?? Be among the first to witness groundbreaking clinical results, including a 12-month follow-up, from the trial of Curespec's #Nephrospec - a revolutionary electro-Hydraulic Acoustic Therapy (eHAt) aimed at lowering blood pressure in hypertensive patients with CKD.??? ? And don't forget to swing by Booth #16 to greet the Curespec team while you're there!??? #ESH2024 #hypertensionawareness #healthinnovation
-
-
#ICYMI Our latest collaborative webinar is now ready to watch on demand. Gain insights on Interprofessional High-Fidelity Cardiopulmonary Resuscitation Simulation. Learn what it is, how to implement large-scale training, and key takeaways.?Presented by experts from the University of Alabama.? ? Request Access:? ? #TrainWithGaumard #HealthcareTraining #MedEd #ClinicalEducation #Trauma?
-
-
Our industry symposium is about to begin! High-sensitivity troponin l from the emergency department (ED) to the Lab. Saturday 2 November, 2:00-3:30 p.m. on Level 2, Rooms C2.2/2.3. This symposium will feature leading experts Professors Paul Collinson, Martin Than, Louise Cullen, Zhong Lu and Dr Camille Chenevier-Gobeaux. The symposium will cover: ? The clinical outcomes, diagnostic performance and user experiences from implementation studies conducted in diverse healthcare settings, demonstrating the real-world efficacy of high-sensitivity troponin l (hsTnI) testing. ? A comprehensive panel discussion exploring the differing perspectives of clinicians and laboratorians on the use of hsTnI assays, highlighting the diagnostic continuum in the management of cardiac markers. #QuidelOrtho #APFCB #Laboratory #ClinicalDiagnostics #QuidelOrthoANZ
-
-
AngioDynamics has published results from the APEX-AV trial in JSCAI. The study, conducted in partnership with The PERT Consortium?, showcases the safety and effectiveness of the AlphaVac F1885 System in treating acute intermediate-risk pulmonary embolism. This collaboration underscores The Consortium’s leadership in advancing PE care and improving patient outcomes. Read more: https://bit.ly/3Pyup7U
-
-
Even in the most complex lesions, #BioMimics3D continues to demonstrate durable results through three years of follow-up.?Please join Veryan Medical at #NCVH May 28-31, booth #321, to learn the latest on outcomes in the most complex patients. Walter Penny Jack Sullivan Joe DeJohn New Cardiovascular Horizons
-
If you're at Advanced Therapies Week, make sure to stop by booth 167 to learn how we can help take your CGT research to the next level! #CGT #ATW25 #AdvancedTherapies #AdvancedTherapiesWeek #CellTherapy #GeneTherapy
-
-
?? We are now firmly back with our feet under the desks following a very busy Advanced Therapies Week in Dallas! It was a very busy week, and our Movers & Shakers series for this show covers a wide breadth of features and activities that took place. ?? To kick us off with the #ATW25 series, Sean Bartholomew and Stephen Ondek from Germfree talk to us about the clinical readiness symposium the Germfree team hosted onsite, aimed at uniting different disciplines within CGT to deliver a 'total solution' for patients at the clinical site. ?? Sean and Stephen go on to share their thoughts on key trends and conversations that are set to shape 2025. ?? Watch their interview below, or catch up on the full Movers & Shakers series from Advanced Therapies Week, here: https://lnkd.in/eiViZFv8 #CellTherapy #GeneTherapy #AdvancedTherapies #DecentralizedManufacturing #ClinicalReadiness Phacilitate
-
The DxFLEX clinical flow cytometer is “incredibly fast and easy to setup,” according to Alan Dunlop, Head of Immunophenotyping at the Royal Marsden NHS Trust. But that’s just the beginning of his story. In this short video, you can hear more from him about how the DxFLEX System has “transformed” his lab. Maybe it can transform your lab, too? Learn more: https://becls.co/4dDOtR4
